[
  {
    "ts": "2025-11-26T00:22:00+00:00",
    "headline": "U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs",
    "summary": "The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening an effort to rein in drug costs.  The new prices, which will take effect in 2027, shave 38% to 85% off the list prices for drugs for diseases including asthma, cancer and diabetes.  The reductions are estimated to save Medicare, the health-insurance program for the elderly, $12 billion.",
    "url": "https://www.wsj.com/health/pharma/u-s-negotiates-lower-prices-for-ozempic-and-14-other-drugs-c410e72c?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "f7d46626-0d75-303c-af88-1b4e9f162f45",
      "content": {
        "id": "f7d46626-0d75-303c-af88-1b4e9f162f45",
        "contentType": "STORY",
        "title": "U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs",
        "description": "",
        "summary": "The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening an effort to rein in drug costs.  The new prices, which will take effect in 2027, shave 38% to 85% off the list prices for drugs for diseases including asthma, cancer and diabetes.  The reductions are estimated to save Medicare, the health-insurance program for the elderly, $12 billion.",
        "pubDate": "2025-11-26T00:22:00Z",
        "displayTime": "2025-11-26T00:22:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f7d46626-0d75-303c-af88-1b4e9f162f45/u-s-negotiates-lower-prices.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/547cf94797ff94b0e2e9fc4177a5f0cc",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/csccUah17wfxhhR1Hs_D0w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/547cf94797ff94b0e2e9fc4177a5f0cc.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MF_aU65NfzMD1GEEzMf.5w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/547cf94797ff94b0e2e9fc4177a5f0cc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/u-s-negotiates-lower-prices-for-ozempic-and-14-other-drugs-c410e72c?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T00:30:02+00:00",
    "headline": "2 Dividend Stocks to Buy Now for Big Payout Growth Ahead",
    "summary": "Merck and Qualcomm combine strong cash flow with steady dividend growth, signaling potential for meaningful payout increases ahead.",
    "url": "https://www.barchart.com/story/news/36316829/2-dividend-stocks-to-buy-now-for-big-payout-growth-ahead",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "6f817a65-7df1-37ff-84a9-6206dff9bb43",
      "content": {
        "id": "6f817a65-7df1-37ff-84a9-6206dff9bb43",
        "contentType": "STORY",
        "title": "2 Dividend Stocks to Buy Now for Big Payout Growth Ahead",
        "description": "",
        "summary": "Merck and Qualcomm combine strong cash flow with steady dividend growth, signaling potential for meaningful payout increases ahead.",
        "pubDate": "2025-11-26T00:30:02Z",
        "displayTime": "2025-11-26T00:30:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/7a001c013d6478f36b63c9346edbba82",
          "originalWidth": 1600,
          "originalHeight": 1054,
          "caption": "Money bag with the word Dividends by Andrii Yalanskyi via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8AbXQLuHyuWf6J2NZjhbww--~B/aD0xMDU0O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/barchart_com_477/7a001c013d6478f36b63c9346edbba82.cf.webp",
              "width": 1600,
              "height": 1054,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ljd0Jvh1WDKM3R0BdHhrVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/7a001c013d6478f36b63c9346edbba82.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/36316829/2-dividend-stocks-to-buy-now-for-big-payout-growth-ahead",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-dividend-stocks-buy-now-003002584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "QCOM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T05:24:23+00:00",
    "headline": "BofA Raises Merck (MRK) Price Target to $105, Keeps Buy Rating",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Stocks to Buy for Medium Term. On November 17, BofA analyst Tim Anderson raised the firm’s price target on Merck & Co., Inc. (NYSE:MRK) to $105 from $98 and maintained a Bu⁠y ratin​g on the share‍s, as reported by The Fly. He‌ de​scribed the Cidara […]",
    "url": "https://finance.yahoo.com/news/bofa-raises-merck-mrk-price-052423637.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "93dce071-0e22-3cd2-a426-38438f7fad32",
      "content": {
        "id": "93dce071-0e22-3cd2-a426-38438f7fad32",
        "contentType": "STORY",
        "title": "BofA Raises Merck (MRK) Price Target to $105, Keeps Buy Rating",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Stocks to Buy for Medium Term. On November 17, BofA analyst Tim Anderson raised the firm’s price target on Merck & Co., Inc. (NYSE:MRK) to $105 from $98 and maintained a Bu⁠y ratin​g on the share‍s, as reported by The Fly. He‌ de​scribed the Cidara […]",
        "pubDate": "2025-11-26T05:24:23Z",
        "displayTime": "2025-11-26T05:24:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/be3393f134c2a187ca00a2f11da1c8b1",
          "originalWidth": 1280,
          "originalHeight": 853,
          "caption": "BofA Raises Merck (MRK) Price Target to $105, Keeps Buy Rating",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rzi36MaDBWV_.B5uoCvsLw--~B/aD04NTM7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/be3393f134c2a187ca00a2f11da1c8b1.cf.webp",
              "width": 1280,
              "height": 853,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Lz1XTvX6T6897fMpEugi1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/be3393f134c2a187ca00a2f11da1c8b1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bofa-raises-merck-mrk-price-052423637.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bofa-raises-merck-mrk-price-052423637.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]